Cetuximab enhances the activities of irinotecan on gastric cancer cell lines through downregulating the EGFR pathway upregulated by irinotecan.
about
Cetuximab plus cisplatin, irinotecan, and thoracic radiotherapy as definitive treatment for locally advanced, unresectable esophageal cancer: a phase-II study of the SWOG (S0414)A multi-center phase II study and biomarker analysis of combined cetuximab and modified FOLFIRI as second-line treatment in patients with metastatic gastric cancer.Targeting C4-demethylating genes in the cholesterol pathway sensitizes cancer cells to EGF receptor inhibitors via increased EGF receptor degradation.Investigational therapies targeting the ErbB family in oesophagogastric cancer.Panitumumab combined with irinotecan for patients with KRAS wild-type metastatic colorectal cancer refractory to standard chemotherapy: a GERCOR efficacy, tolerance, and translational molecular study.The Role of Kinase Modulators in Cellular Senescence for Use in Cancer Treatment.
P2860
Cetuximab enhances the activities of irinotecan on gastric cancer cell lines through downregulating the EGFR pathway upregulated by irinotecan.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Cetuximab enhances the activit ...... way upregulated by irinotecan.
@en
Cetuximab enhances the activit ...... way upregulated by irinotecan.
@nl
type
label
Cetuximab enhances the activit ...... way upregulated by irinotecan.
@en
Cetuximab enhances the activit ...... way upregulated by irinotecan.
@nl
prefLabel
Cetuximab enhances the activit ...... way upregulated by irinotecan.
@en
Cetuximab enhances the activit ...... way upregulated by irinotecan.
@nl
P2093
P2860
P1476
Cetuximab enhances the activit ...... way upregulated by irinotecan.
@en
P2093
P2860
P2888
P304
P356
10.1007/S00280-011-1559-2
P577
2011-02-01T00:00:00Z